RARE-51. RITUXIMAB, METHOTREXATE, BCNU, ETOPOSIDE, AND PREDNISONE (RMBVP) FOR THE TREATMENT OF RELAPSED/RECURRENT PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A RETROSPECTIVE SINGLE CE...

door Reiss, Samantha, Yerram, Prakirthi, Modelevsky, Lisa, Grommes, Christian
Gepubliceerd in Neuro Oncol (2019)

Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas

door Reiss, Samantha N., Yerram, Prakirthi, Modelevsky, Lisa, Grommes, Christian
Gepubliceerd in J Immunother Cancer (2017)

ACTR-94. TOXICITY OF SINGLE AGENT CARMUSTINE VERSUS CARMUSTINE PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT OR PROGRESSIVE HIGH GRADE GLIOMAS

door Yerram, Prakirthi, Reiss, Samantha, Modelevsky, Lisa, Gavrilovic, Igor, Kaley, Thomas
Gepubliceerd in Neuro Oncol (2017)

Evaluation of toxicity of carmustine with or without bevacizumab in patients with recurrent or progressive high grade gliomas

door Yerram, Prakirthi, Reiss, Samantha N, Modelevsky, Lisa, Gavrilovic, Igor T, Kaley, Thomas
Gepubliceerd in J Neurooncol (2019)

Rapid infusion rituximab is well tolerated in patients with primary CNS lymphoma

door Modelevsky, Lisa, Tizon, Richard, Reiss, Samantha N, Smith, Marcel, Garonce, Rachel, Kaley, Thomas
Gepubliceerd in CNS Oncol (2018)

Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City

door Yerram, Prakirthi, Thackray, Jennifer, Modelevsky, Lisa R, Land, Josiah D, Reiss, Samantha N, Spatz, Krisoula H, Levoir, Andrea C, Pak, Terry K, Dao, Phuong H, Buege, Michael J, Derespiris, Lauren M, Lau, Carmen, Orozco, Jennifer S, Boparai, Manpreet, Koranteng, Lauren A, Reichert, Kate E, Yan, Shirley Q, Daukshus, Nicole P, Mathew, Sherry, Buie, Larry W, Tizon, Richard F, Freeswick, Scott, Liu, Dazhi, Harnicar, Stephen
Gepubliceerd in J Oncol Pharm Pract (2021)